miR-345 in Metastatic Colorectal Cancer: A Non-Invasive Biomarker for Clinical Outcome in Non-KRAS Mutant Patients Treated with 3rd Line Cetuximab and Irinotecan
出版年份 2014 全文链接
标题
miR-345 in Metastatic Colorectal Cancer: A Non-Invasive Biomarker for Clinical Outcome in Non-KRAS Mutant Patients Treated with 3rd Line Cetuximab and Irinotecan
作者
关键词
-
出版物
PLoS One
Volume 9, Issue 6, Pages e99886
出版商
Public Library of Science (PLoS)
发表日期
2014-06-19
DOI
10.1371/journal.pone.0099886
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- MicroRNA Biomarkers in Whole Blood for Detection of Pancreatic Cancer
- (2014) Nicolai A. Schultz et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Identification of serum microRNA profiles in colon cancer
- (2013) E Hofsli et al. BRITISH JOURNAL OF CANCER
- Serum miR-21 as a Diagnostic and Prognostic Biomarker in Colorectal Cancer
- (2013) Yuji Toiyama et al. JNCI-Journal of the National Cancer Institute
- EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2
- (2013) Jia Shen et al. NATURE
- The shaping and functional consequences of the microRNA landscape in breast cancer
- (2013) Heidi Dvinge et al. NATURE
- Identification and Evaluation of Plasma MicroRNAs for Early Detection of Colorectal Cancer
- (2013) Xiaoya Luo et al. PLoS One
- Plasma Processing Conditions Substantially Influence Circulating microRNA Biomarker Levels
- (2013) Heather H. Cheng et al. PLoS One
- Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer
- (2012) M Pichler et al. BRITISH JOURNAL OF CANCER
- Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial
- (2012) A Madi et al. BRITISH JOURNAL OF CANCER
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls
- (2012) Zhibin Hu et al. CARCINOGENESIS
- Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study
- (2012) Kjell Magne Tveit et al. JOURNAL OF CLINICAL ONCOLOGY
- CirculatingmiR-34alevels are reduced in colorectal cancer
- (2012) M. Nugent et al. JOURNAL OF SURGICAL ONCOLOGY
- MicroRNA Expression Profiles of Whole Blood in Lung Adenocarcinoma
- (2012) Santosh K. Patnaik et al. PLoS One
- MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer
- (2011) Jie-Ting Tang et al. CARCINOGENESIS
- MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
- (2011) Kasey C. Vickers et al. NATURE CELL BIOLOGY
- Characterization of extracellular circulating microRNA
- (2011) Andrey Turchinovich et al. NUCLEIC ACIDS RESEARCH
- Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis
- (2011) Hanyin Cheng et al. PLoS One
- MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer
- (2011) Mattia Boeri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases
- (2010) Vlastimil Kulda et al. CANCER GENETICS AND CYTOGENETICS
- Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells
- (2010) Nobuyoshi Kosaka et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression
- (2010) Xing-xiang Pu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- DIANA-mirPath: Integrating human and mouse microRNAs in pathways
- (2009) G. L. Papadopoulos et al. BIOINFORMATICS
- Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer
- (2009) Greg M Arndt et al. BMC CANCER
- Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening
- (2009) E K O Ng et al. GUT
- Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer
- (2009) Zhaohui Huang et al. INTERNATIONAL JOURNAL OF CANCER
- KRASandBRAFMutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS Trial
- (2009) Susan D. Richman et al. JOURNAL OF CLINICAL ONCOLOGY
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
- (2009) Eric Van Cutsem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of miR-143 targeting KRAS in colorectal tumorigenesis
- (2009) X Chen et al. ONCOGENE
- Targeted KRAS Mutation Assessment on Patient Tumor Histologic Material in Real Time Diagnostics
- (2009) Vassiliki Kotoula et al. PLoS One
- Standardization of real-time PCR gene expression data from independent biological replicates
- (2008) Erik Willems et al. ANALYTICAL BIOCHEMISTRY
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
- (2008) Xi Chen et al. CELL RESEARCH
- Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer
- (2008) Carsten Bokemeyer et al. JOURNAL OF CLINICAL ONCOLOGY
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
- DxS Ltd
- (2008) Joanne Cross PHARMACOGENOMICS
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now